Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

481

Reviewed by James Ives, MPsych Mar 28 2019 A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.

Ga naar Bron